Prognostic value of tissue inhibitor of metalloproteinase-matrix metalloproteinase biomarkers at 30 days in patients with acute myocardial infarction without reperfusion therapy.
10.1097/CM9.0000000000001144
- Author:
Hui-Fang PANG
1
;
Yan GAO
;
Jia-Min LIU
;
Jia-Peng LU
;
Yan-Ping WANG
;
Si-Ming WANG
;
Li-Bo HOU
;
Ao-Xi TIAN
;
Yan GAO
Author Information
1. National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing 100037, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers;
Humans;
Matrix Metalloproteinases;
Myocardial Infarction;
Prognosis;
Reperfusion;
Tissue Inhibitor of Metalloproteinase-1;
Tissue Inhibitor of Metalloproteinases
- From:
Chinese Medical Journal
2020;134(4):481-483
- CountryChina
- Language:English
